John Lunger Adaptimmune Therapeutics PLC (ADAP) insider trading activity

ADAP Quotes by TradingView

John Lunger is Chief Patient Supply Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 19,015 shares of ADAP, which is worth approximately $13,880. The most recent transaction as insider was on Jan 17, 2024, when has been sold 18,114 shares (American Depositary Shares representing Ordinary Shares) at a price of $0.67 per share, resulting in proceeds of $12,136. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19K
0% 3M change
303.03% 12M change
Total Value Held $13,880

John Lunger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2024
SELL
Open market or private sale
$12,136 $0.67 p/Share
18,114 Reduced 48.79%
19,015 American Depositary Sh...
Jan 16 2024
SELL
Open market or private sale
$3,697 $0.79 p/Share
4,681 Reduced 39.99%
7,023 American Depositary Sh...
Jan 12 2024
SELL
Open market or private sale
$4,437 $0.85 p/Share
5,220 Reduced 39.87%
7,874 American Depositary Sh...
Jan 11 2024
SELL
Open market or private sale
$3,367 $0.84 p/Share
4,009 Reduced 39.64%
6,104 American Depositary Sh...
Aug 01 2023
SELL
Open market or private sale
$2,817 $0.91 p/Share
3,096 Reduced 39.62%
4,718 American Depositary Sh...
Jan 17 2023
SELL
Open market or private sale
$8,258 $1.86 p/Share
4,440 Reduced 37.94%
7,264 American Depositary Sh...
Jan 12 2023
SELL
Open market or private sale
$8,503 $1.71 p/Share
4,973 Reduced 37.98%
8,121 American Depositary Sh...
Jan 11 2023
SELL
Open market or private sale
$6,725 $1.75 p/Share
3,843 Reduced 38.0%
6,270 American Depositary Sh...
Jan 04 2023
SELL
Open market or private sale
$1,859 $1.69 p/Share
1,100 Reduced 38.94%
1,725 American Depositary Sh...
Aug 01 2022
SELL
Open market or private sale
$5,280 $1.77 p/Share
2,983 Reduced 38.18%
4,829 American Depositary Sh...
Jul 05 2022
SELL
Open market or private sale
$3,315 $1.68 p/Share
1,973 Reduced 38.86%
3,104 American Depositary Sh...
Jan 18 2022
SELL
Open market or private sale
$13,934 $3.19 p/Share
4,368 Reduced 37.32%
7,336 American Depositary Sh...
Jan 12 2022
SELL
Open market or private sale
$3,809 $3.54 p/Share
1,076 Reduced 38.09%
1,749 American Depositary Sh...
Jan 11 2022
SELL
Open market or private sale
$13,421 $3.56 p/Share
3,770 Reduced 37.28%
6,343 American Depositary Sh...
Jan 04 2022
SELL
Open market or private sale
$4,344 $4.06 p/Share
1,070 Reduced 37.88%
1,755 American Depositary Sh...
Aug 02 2021
SELL
Open market or private sale
$10,522 $3.58 p/Share
2,939 Reduced 37.62%
4,873 American Depositary Sh...
Jul 02 2021
SELL
Open market or private sale
$8,124 $4.26 p/Share
1,907 Reduced 37.56%
3,170 American Depositary Sh...
Jan 19 2021
SELL
Open market or private sale
$24,710 $5.67 p/Share
4,358 Reduced 37.24%
7,346 American Depositary Sh...
Jan 12 2021
SELL
Open market or private sale
$6,507 $6.15 p/Share
1,058 Reduced 37.45%
1,767 American Depositary Sh...
Jan 04 2021
SELL
Open market or private sale
$5,676 $5.33 p/Share
1,065 Reduced 37.7%
1,760 American Depositary Sh...

Also insider at

GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
Director
JL

John Lunger

Chief Patient Supply Officer
Abingdon, X0

Track Institutional and Insider Activities on ADAP

Follow Adaptimmune Therapeutics PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADAP shares.

Notify only if

Insider Trading

Get notified when an Adaptimmune Therapeutics PLC insider buys or sells ADAP shares.

Notify only if

News

Receive news related to Adaptimmune Therapeutics PLC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADAP